Services • EYE CARE


Optic neuritis

Optic neuritis is the inflammation of the optic nerve, which transmits visual information from the eye to the brain. It is often associated with autoimmune disorders such as multiple sclerosis (MS) or can occur as an isolated condition.

Optic neuritis commonly presents with sudden vision loss, blurred or dimmed vision, eye pain, and reduced color perception. It may affect one or both eyes.

Treatment aims to reduce inflammation and manage underlying conditions, and it may involve corticosteroid medications and other immune-modulating therapies. Most individuals with optic neuritis recover their vision, but some may experience long-term visual impairment or recurrence of symptoms. Prompt medical is crucial for proper diagnosis and management.



Multiple sclerosis

Multiple sclerosis (MS) can cause various ocular signs due to the involvement of the central nervous system.

Optic neuritis is a common early symptom, characterized by inflammation of the optic nerve, resulting in blurred or reduced vision, eye pain, and color vision problems. Other ocular manifestations may include double vision (diplopia) due to cranial nerve involvement, nystagmus (involuntary eye movement), and problems with eye coordination. These ocular signs can be temporary or recurrent, and they may affect one or both eyes.

It is essential for individuals experiencing these symptoms to consult with a healthcare professional for proper evaluation, diagnosis, and appropriate management of MS.



Myasthenia gravis

Myasthenia gravis (MG) is an autoimmune disorder that affects the neuromuscular junction, leading to muscle weakness and fatigue.

Ocular signs of MG commonly include ptosis (drooping of the eyelids) and diplopia (double vision) that worsen with prolonged use of the affected eye muscles. Other ocular symptoms may include blurred vision, difficulty maintaining eye alignment, and eyelid weakness, causing difficulties in fully opening the eyes.

These ocular signs often improve with rest or after treatment with medications that enhance neuromuscular transmission. A comprehensive evaluation is important for diagnosing and managing MG-related ocular manifestations.